The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)
Abstract
BACKGROUND: Cardiovascular disease, the most common cause of death with a functioning graft among kidney transplant recipients, can be exacerbated by immunosuppressive drugs, particularly the calcineurin inhibitors. Belatacept, a selective co-stimulation blocker, may provide a better cardiovascular/metabolic risk profile than current immunosuppressants. METHODS: Cardiovascular and metabolic endpoints from two Phase III studies (BENEFIT and BENEFIT-EXT) of belatacept-based regimens in kidney transplant recipients were assessed at month 12. Each study assessed belatacept in more intensive (MI) and less intensive (LI) regimens versus cyclosporine A (CsA). These secondary endpoints included changes in blood pressure, changes in serum lipids, and the incidence of new-onset diabetes after transplant (NODAT). RESULTS: A total of 1209 patients were randomized and transplanted across the two studies. Mean systolic blood pressure was 6 to 9 mm Hg lower and mean diastolic blood pressure was 3 to 4 mm Hg lower in the MI and LI groups versus CsA (P ≤ 0.002) across both studies at month 12. Non-HDL cholesterol was lower in the belatacept groups versus CsA (P<0.01 MI or LI vs. CsA in each study). Serum triglycerides were lower in the belatacept groups versus CsA (P<0.02 MI or LI vs. CsA in each study). NODAT occurred less often in the belatacept groups versus CsA in a prespecified pooled analysis (P<0.05 MI or LI vs. CsA). CONCLUSIONS: At month 12, belatacept regimens were associated with better cardiovascular and metabolic risk profiles, with lower blood pressure and serum lipids and less NODAT versus CsA. The overall profile of belatacept will continue to be assessed over the 3-year trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An additional consideration is that men with CMD, whether characterized by prediabetes, metabolic syndrome, obesity, or T2D, are at increased risk of hypogonadism and testosterone deficiency.1566–1569”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1569]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Diabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202
Pirsch, J. D., Miller, J., Deierhoi, M. H., Vincenti, F., & Filo, R. S. (1997) · Transplantation · doi:10.1097/00007890-199704150-00013 · Cited by 1,122
Self-citationVincenti, F., Charpentier, B., Vanrenterghem, Y., Rostaing, L., Bresnahan, B., Darji, P., Massari, P., Mondragon‐Ramirez, G. A., Agarwal, M., Di Russo, G., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.03005.x · Cited by 957
Self-citationManjunath, G., Tighiouart, H., Ibrahim, H., MacLeod, B., Salem, D. N., Griffith, J. L., Coresh, J., Levey, A. S., & Sarnak, M. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02663-3 · Cited by 920
Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
Muntner, P., He, J., Hamm, L., Loria, C., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 829
Mayer, A. D., Dmitrewski, J., Squifflet, J.-P., Besse, T., Grabensee, B., Klein, B., Eigler, F. W., Heemann, U., Pichlmayr, R., Behrend, M., et al. (1997) · Transplantation · doi:10.1097/00007890-199708150-00012 · Cited by 724
Self-citationLarsen, C. P., Pearson, T. C., Adams, A. B., Tso, P., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S., Price, K., Naemura, J., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 723
Self-citationNon–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 658
Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J. M., Uchida, K., Pescovitz, M. D., Marchetti, P., Tuncer, M., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01749.x · Cited by 619
Self-citationAssociation of chronic kidney graft failure with recipient blood pressure
Opelz, G., Wujciak, T., Ritz, E., & Study, F. T. C. T. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00744.x · Cited by 596
Durrbach, A., Pestana, J. M., Pearson, T., Vincenti, F., Garcia, V. D., Campistol, J., Del Carmen Rial, M., Florman, S., Block, A., Di Russo, G., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03016.x · Cited by 570
Self-citationPischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514
Cardiovascular Complications After Renal Transplantation and Their Prevention
Ojo, A. O. (2006) · Transplantation · doi:10.1097/01.tp.0000235527.81917.fe · Cited by 450
Hypertension after kidney transplantation
Kasiske, B. L., Anjum, S., Shah, R., Skogen, J., Kandaswamy, C., Danielson, B., O’Shaughnessy, E. A., Dahl, D. C., Silkensen, J. R., Sahadevan, M., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.013 · Cited by 422
Cosio, F. G., Kudva, Y., van der Velde, M., Larson, T. S., Textor, S. C., Griffin, M. D., & Stegall, M. D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00349.x · Cited by 394
Flechner, S. M., Goldfarb, D., Modlin, C., Feng, J., Krishnamurthi, V., Mastroianni, B., Savas, K., Cook, D. J., & Novick, A. C. (2002) · Transplantation · doi:10.1097/00007890-200210270-00002 · Cited by 375
Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
Johnston, O., Rose, C. L., Webster, A. C., & Gill, J. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111202 · Cited by 359
Meier-Kriesche, H.-U., Baliga, R., & Kaplan, B. (2003) · Transplantation · doi:10.1097/01.tp.0000061602.03327.e2 · Cited by 327
Arterial Hypertension and Renal Allograft Survival
Mange, K. C. (2000) · JAMA · doi:10.1001/jama.283.5.633 · Cited by 293
Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient Survival
Cole, E. H., Johnston, O., Rose, C. L., & Gill, J. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04681107 · Cited by 226
Cardiovascular morbidity and risk factors in renal transplant patients
Aakhus, S., Dahl, K., & Wideroe, T. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.3.648 · Cited by 214
Vanrenterghem, Y., Lebranchu, Y., Hen??, R., Oppenheimer, F., & Ekberg, H. (2000) · Transplantation · doi:10.1097/00007890-200011150-00015 · Cited by 213
Self-citationMortality after kidney transplant failure: The impact of non-immunologic factors
Gill, J. S., Abichandani, R., Kausz, A. T., & Pereira, B. J. G. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00640.x · Cited by 208
Silva, H., Yang, H., Abouljoud, M., Kuo, P., Wisemandle, K., Bhattacharya, P., Dhadda, S., Holman, J., Fitzsimmons, W., & Roy First, M. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01661.x · Cited by 177
Maruyama, C., Imamura, K., & Teramoto, T. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.186 · Cited by 173
Hanak, V., Munoz, J., Teague, J., Stanley, A., & Bittner, V. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.069 · Cited by 167
Cyclosporin-Induced Hypertension: Incidence, Pathogenesis and Management
Taler, S. J., Textor, S. C., Canzanello, V. J., & Schwartz, L. (1999) · Drug Safety · doi:10.2165/00002018-199920050-00004 · Cited by 161
Risk Factors for Cardiovascular Events After Successful Renal Transplantation
Vanrenterghem, Y. F. C., Claes, K. J., Montagnino, G., Fieuws, S., Maes, B., Villa, M. N., & Ponticelli, C. E. (2008) · Transplantation · doi:10.1097/tp.0b013e318160254f · Cited by 151
Self-citationAakhus, S., Dahl, K. J., & Widerøe, T. E. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00235.x · Cited by 133
Hjelmesaeth, J. S., Hartmann, A., Kofstad, J., Egeland, T., Stenstrøm, J., & Fauchald, P. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.4.829 · Cited by 133
Fellström, B., Jardine, A. G., Soveri, I., Cole, E., Neumayer, H., Maes, B., Gimpelewicz, C. R., & Holdaas, H. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00983.x · Cited by 117
Self-citationOpelz, G., & Döhler, B. (2009) · Transplantation · doi:10.1097/tp.0b013e318199c1c7 · Cited by 116
Drug-related dyslipidemia after renal transplantation
Mathis, A. S., Dave, N. J., Knipp, G. T., & Friedman, G. S. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.6.565 · Cited by 97
Blum, C. B. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20610.x · Cited by 92
van den Ham, E. C. H., Kooman, J. P., Christiaans, M. H. L., Nieman, F. H. M., & van Hooff, J. P. (2003) · Transplant International · doi:10.1111/j.1432-2277.2003.tb00304.x · Cited by 91
van den Ham, E. C. H., Kooman, J. P., Christiaans, M. H. L., et al. (2003) · PubMed · doi:10.1007/s00147-002-0502-1 · Cited by 83
Hsia, S. H., Pan, D., Berookim, P., & Lee, M. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.05.024 · Cited by 81
ORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW
Nankivell, B. J., Chapman, J. R., Bonovas, G., & Gruenewald, S. M. (2004) · Transplantation · doi:10.1097/01.tp.0000121196.71904.e0 · Cited by 77
Coronary Artery Calcification in Renal Transplant Recipients
Rosas, S. E., Mensah, K., Weinstein, R. B., Bellamy, S. L., & Rader, D. J. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00955.x · Cited by 69
Fellström, B., Holdaas, H., Jardine, A. G., Nyberg, G., Grönhagen‐Riska, C., Madsen, S., Neumayer, H., Cole, E., Maes, B., Ambühl, P. M., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000147338.34323.12 · Cited by 64
Self-citationRoland, M., Gatault, P., Doute, C., Büchler, M., Al-Najjar, A., Barbet, C., Châtelet, V., Marliere, J.-F., Nivet, H., Lebranchu, Y., et al. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00640.x · Cited by 63
Fellstr�m, B. C., Jardine, A. G., Soveri, I., Cole, E., nhagen-Riska, C. G., Neumayer, H. H., Maes, B., Gimpelewicz, C. R., & Holdaas, H. (2005) · Transplantation · doi:10.1097/01.tp.0000160764.35083.b8 · Cited by 61
Self-citationGaber, A. O., Kahan, B. D., Buren, C. T. V., Schulman, S. L., Scarola, J. A., & Neylan, J. F. (2008) · Transplantation · doi:10.1097/tp.0b013e318187bab0 · Cited by 59
Hypertension in renal transplantation: donor and recipient risk factors
Ducloux, D., Motte, G., Kribs, M., Abdelfatah, A., Bresson–Vautrin, C., Rebibou, J.-M., & Chalopin, J. M. (2002) · Clinical Nephrology · doi:10.5414/cnp57409 · Cited by 56
Pre-transplant predictors of cerebrovascular events after kidney transplantation
Aull‐Watschinger, S., Konstantin, H., Demetriou, D., Schillinger, M., Habicht, A., Hörl, W. H., & Watschinger, B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm766 · Cited by 55
Hernández, D., Miquel, R., Porrini, E., Fernández, A. M., González‐Posada, J. M., Hortal, L., Checa, M. D., Rodríguez, A., García, J. J., Rufino, M., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000282872.17024.b7 · Cited by 49
Cosio, F. G., Pelletier, R. P., Sedmak, D. D., Pesavento, T. E., Henry, M. L., & Ferguson, R. M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00752.x · Cited by 46
Impact of diabetes mellitus on kidney transplant recipients in Spain
González‐Posada, J. M., Hernández, D., Genís, B. B., Perez, J. G., & Rivero, M. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1017 · Cited by 46
New-Onset Diabetes Mellitus After Kidney Transplantation: The Role of Immunosuppression
Veroux, M., Corona, D., Giuffrida, G., Gagliano, M., Sorbello, M., Virgilio, C., Tallarita, T., Zerbo, D., Giaquinta, A., Fiamingo, P., et al. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.06.005 · Cited by 45
Luan, F. L., Zhang, H., Schaubel, D. E., Miles, C. D., Cibrik, D. M., Norman, S. P., & OJO, A. O. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02328.x · Cited by 42
Deleuze, S., Garrigue, V., Delmas, S., Chong, G., Swarcz, I., Cristol, J. P., & Mourad, G. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.06.125 · Cited by 39
Legendre, C., Campistol, J. M., Squifflet, J.-P., & Burke, J. T. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00241-0 · Cited by 38
Self-citationFactors Predicting Long‐term Graft Survival after Kidney Transplantation: Multicenter Study in Japan
Akioka, K., Takahara, S., Ichikawa, S., Yoshimura, N., Akiyama, T., & Ohshima, S. (2005) · World Journal of Surgery · doi:10.1007/s00268-005-7531-8 · Cited by 30
Díaz, J. M., Gich, I. J., Bonfill, X., Solà, R., Guirado, L., Facundo, C., Sainz, Z., Puig, T., Silva, I., & Ballarín, J. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.06.134 · Cited by 30
Charpentier, B., Groth, C. G., Bäckman, L., Morales, J. M., Calne, R. Y., Kreis, H., Lang, P., Touraine, J. L., Claesson, K., Campistol, J. M., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00213-6 · Cited by 29
Self-citationSchiel, R., Heinrich, S., Steiner, T., Ott, U., & Stein, G. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0346-y · Cited by 28
Jogestrand, T., Fehrman‐Ekholm, I., Angelin, B., Berglund, L., & Gäbel, H. (1996) · PubMed · Cited by 26
Arterial Elasticity Measurement in Renal Transplant Patients Under Anticalcineurin Immunosuppression
Martínez‐Castelao, A., Sarriás, X., Bestard, O., Gil‐Vernet, S., Serón, D., Cruzado, J. M., Moreso, F., Díez-Noguera, A., & Grinyo, J. M. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.10.078 · Cited by 25
Lietz, K., Lewandowski, Z., Lao, M., Pączek, L., & Gaciong, Z. A. (2004) · Transplant International · doi:10.1007/s00147-003-0664-5 · Cited by 18
Blood Pressure and Graft Outcome in Renal Transplantation
Berber, İ., Aydin, C., Yiğit, B., Kara, V. M., Yıldar, M., Düzyol, Ç., Türkmen, F., Titiz, M. İ., & Altaca, G. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.01.021 · Cited by 16
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
Basile, J. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02009.x · Cited by 16
Research works printed but not linked: 1
- 2003, Introduction, assessment of dyslipidemias, treating dyslipidemias, and research recommendations., Am J Kidney Dis, 41, S11
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Prevention of cardiovascular disease in adult recipients of kidney transplants
Jardine, A. G., Gaston, R. S., Fellstrom, B. C., & Holdaas, H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61334-2 · Cited by 281
Post-transplant diabetes mellitus in patients with solid organ transplants
Jenssen, T., & Hartmann, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0137-7 · Cited by 278
Rostaing, L., Vincenti, F., Grinyó, J., Rice, K. M., Bresnahan, B., Steinberg, S., Gang, S., Gaite, L. E., Moal, M.-C., Mondragón-Ramirez, G. A., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12460 · Cited by 197
Self-citationLong-Term Immunosuppression Management: Opportunities and Uncertainties
Wojciechowski, D., & Wiseman, A. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15040920 · Cited by 170
Metadata
- Authors
- Vanrenterghem, Y., Bresnahan, B., Campistol, J., Durrbach, A., Grinyó, J., Neumayer, H.-H., Lang, P., Larsen, C. P., Mancilla-Urrea, E., Pestana, J. M., Block, A., Duan, T., Glicklich, A., Gujrathi, S., & Vincenti, F.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Medical College of Wisconsin (US)
- Hospital Clínic de Barcelona (ES)
- Charité – Universitätsmedizin Berlin (DE)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Emory University (US)
- Instituto Nacional de Cardiología (MX)
- University of California, San Francisco (US)
- Corresponding author
- Vanrenterghem, Yves
- Venue
- Transplantation
- Published
- 2011-05-15
- Volume
- 91
- Issue
- 9
- Pages
- 976-983
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1976465544
- Cited by
- 183
- References
- 67
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 10 · 2020: 5 · 2019: 11 · 2018: 8 · 2017: 10 · 2016: 11 · 2015: 15 · 2014: 24 · 2013: 13 · 2012: 24
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- belatacept, cyclosporine, kidney transplantation, cardiovascular risk, metabolic risk, blood pressure, serum lipids, non-HDL cholesterol, triglycerides, post-transplant diabetes mellitus, calcineurin inhibitors, immunosuppressive regimens, costimulation blockade
- MeSH terms
- Abatacept, Adult, Aged, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Immunosuppressive Agents, Lipids, Male, Middle Aged, Risk Factors, Kidney Transplantation, Cyclosporine, Immunoconjugates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.